(Q54707080)

English

Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

0 references

Shailendra K. Saxena

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Rentala Madhubala

object named as

Rentala Madhubala

4

0 references

author name string

Poonam Tewary

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Bindu Sukumaran

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

22

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

23-24

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

3053-3060

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Visceral leishmaniasis: more prevalent and more problematic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

DNA vaccines: technology and application as anti-parasite and anti-microbial agents

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

based on heuristic

inferred from DOI database lookup

Designer vaccines for parasitic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunization with recombinant LD1 antigens protects against experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Leishmania vaccines: old and new.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Leishmania donovani: Characterization and Expression of ORFF, a Gene Amplified from the LDI Locus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

A frequently amplified region in Leishmania contains a gene conserved in prokaryotes and eukaryotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

A multicopy, extrachromosomal DNA in Leishmania infantum contains two inverted repeats of the 27.5-kilobase LD1 sequence and encodes numerous transcripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG motifs as immune adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.007

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.02.007

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15297055

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54707080&oldid=1775335155"